AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Sees Volatile Trading - Up $0.30

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Sees Volatile Trading - Up $0.30

Its down 0.25, from 1 in 2017Q1. In current trading day Kadmon Holdings, Inc.

While having a peek at profitability ratios Acelrx Pharmaceutica (NASDAQ:ACRX) has trailing twelve month gross margin at 13.9%, its trailing twelve month operating margin stands at 0% whereas its trailing twelve month net profit margin spots at 0%. According to these analysts, the Low Revenue Estimate for AcelRx Pharmaceuticals, Inc.is 100 Million and the High Revenue Estimate is 3.8 Million. With an institutional ownership near 0%, it carries an earnings per share ratio of -0.93. Northern Trust Corporation holds 56,061 shares. Osterweis Capital Inc holds 0% in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) or 10,339 shares. Group Inc One Trading L P holds 8,291 shares. Da Davidson And reported 61,900 shares or 0% of all its holdings. Grt Capital Partners Ltd Liability holds 49,761 shares or 0.06% of its portfolio. Meeder Asset Management stated it has 0% of its portfolio in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX). The company had Year Ago Sales of 3.37 Million. The shares were purchased at an average price of $3.24. Following multiple time frames using moving averages can help investors figure out where the stock has been and help determine where it may be possibly going. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 5.15M shares traded or 181.42% up from the average.

The stock of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is a huge mover today! It has underperformed by 30.94% the S&P500. Next quarter's EPS is expected be $-0.25 with next year's EPS projected to be $-0.84. At present, 0 analysts call it Sell, while 2 think it is Hold. Therefore 75% are positive. AcelRx Pharmaceuticals has $15 highest and $300 lowest target. Institutional ownership can eventually exceed 100 percent of float, which means that, in addition to all the available shares, institutions have also bought up all the borrowed shares from short sellers who are betting that the stock will decline. Average estimation for the current quarter has been provided by 6 analysts. The firm earned "Buy" rating on Friday, August 4 by H.C. Wainwright. Out of the analyst recommendations 1 rate Acelrx Pharmaceutica (NASDAQ:ACRX) stock a Buy, 3 rate the stock Outperform, 2 rate Hold, 0 rate Underperform and 0 recommend a Sell. The firm has "Buy" rating by H.C. Wainwright given on Tuesday, May 3. Stifel Nicolaus maintained Caesarstone Ltd (NASDAQ:CSTE) on Wednesday, August 2 with "Buy" rating. The forecast of 4 surveyed investment analysts covering the stock advises investors to Buy stake in the company. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. (NASDAQ:ACRX). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.20. (ACRX) in the open market. The firm has "Buy" rating by TH Capital given on Monday, October 5. (NASDAQ:ACRX) shares slumped after saying the US Food and Drug Administration (FDA) did not approve its new drug application for pain treatment Dsuvia in its present form. More interesting news about AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) was released by: Seekingalpha.com and their article: "AcelRx Remains An Attractive Buy After Strong Run" with publication date: October 10, 2017.

AcelRx Pharmaceuticals, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Development Officer Hamel Lawrence G has sold 10,161 shares of AcelRx Pharmaceuticals, Inc. The total amount of shares outstanding is 46.95 million, giving the company a market capitalization of about 258.23 million. The Firm operates through the segment, which includes development and commercialization of product candidates for the treatment of pain.

Related Articles

  • Spain crashed returning from the parade fighter

    Spain crashed returning from the parade fighter

    Thursday's parade saw the participation of 3,900 military personal, along with 78 different aircraft, including four Eurofighters. The crash reportedly took place near a public park, just south of Albacete called La Pulgosa.
    Prosecutors Open Bribery Case Against PSG President

    Prosecutors Open Bribery Case Against PSG President

    Valcke was FIFA's CEO-like secretary general under then-president Sepp Blatter from 2007 until he was sacked in January 2016.
    Astronomers have discovered a dwarf planet in the Solar system ring

    Astronomers have discovered a dwarf planet in the Solar system ring

    But it's too soon to say for sure whether Haumea really doesn't match up to this criteria. Width of the ring of the dwarf planet Haumea is located 70 km radius - 2287 km.
  • (CTSH) is down at $73.60 Cognizant Schedules Third Quarter 2017…

    On Monday, October 9 the stock rating was maintained by Bank of America with "Buy". (NASDAQ:AAPL) rating on Wednesday, August 2. Mawer Inv Management Ltd invested 0% of its portfolio in General Electric Company (NYSE:GE). (NASDAQ:AAPL) for 9,348 shares.
    Gal Gadot in talks to star in Nazi revenge thriller Ruin

    Gal Gadot in talks to star in Nazi revenge thriller Ruin

    Further, the Israeli actress is set to showcase her acting skills in forthcoming film , as she fights against the evil Germans . This year's " Wonder Woman " was a blockbuster for Warner Bros . with $821 million in worldwide box office.
    Del Potro beats Zverev to enter Shanghai Masters quarters

    Del Potro beats Zverev to enter Shanghai Masters quarters

    Del Potro dropped his opening service game of the match as Zverev took the first set comfortably in just 26 minutes. Earlier, sixth-seeded Grigor Dimitrov of Bulgaria got past Sam Querrey of the US 6-3, 7-6 (3) in the round of 16.
  • Abbott Laboratories (ABT) Stock Rating Upgraded by Zacks Investment Research

    Abbott Laboratories (ABT) Stock Rating Upgraded by Zacks Investment Research

    Indicating how profitable Abbott Laboratories (NYSE: ABT ) is relative to its assets, the ROA value is displayed at 2.00%. The stock of Abbott Laboratories (NYSE: ABT ) has "Outperform" rating given on Wednesday, March 1 by RBC Capital Markets.
    Dove admits it 'missed the mark' with whitewashing ad

    Dove admits it 'missed the mark' with whitewashing ad

    Dove has tried over the years to make a socially conscious stance on beauty by including women of all races, sizes, and age. The black woman takes off her shirt to reveal a white woman and the last image reveals the woman to be Asian.
    Breaking Bad house owners build fence after pizza stunts

    Breaking Bad house owners build fence after pizza stunts

    And Frank Sandoval, who runs the Breaking Bad RV Tours, says he completely understands. KOB's news crew themselves counted around 10 tourists hanging around the home.
  • Analyst Scores Summary: Chesapeake Energy Corporation (CHK), Sears Holdings Corporation (SHLD)

    Analyst Scores Summary: Chesapeake Energy Corporation (CHK), Sears Holdings Corporation (SHLD)

    Keeping an eyeball on Moving Averages, the 50-day is 4.002; the 200-day is at 4.828, for Chesapeake Energy Corporation (CHK ). The highest price CHK stock touched in the last 12 month was $8.2 and the lowest price it hit in the same period was $3.55.

    Spain beats Albania to score World Cup berth

    A 2-0 win over Moldova at the Aviva Stadium on Friday night has given Ireland one final chance, which they must take. Wales will start as favourites because they have home advantage, but it should be very close to call.
    Analyst Research Roundup: Ichor Holdings, Ltd. (ICHR), Philip Morris International Inc. (PM)

    Analyst Research Roundup: Ichor Holdings, Ltd. (ICHR), Philip Morris International Inc. (PM)

    The technology company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.60 by ($0.02). Moreover, Great West Life Assurance Can has 0% invested in Popular Inc (NASDAQ:BPOP) for 11,367 shares.